Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease

Published:2014-12 Issue:12 Volume:12 Page:2092-2103.e6
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Chachay Veronique S.,Macdonald Graeme A.,Martin Jennifer H.,Whitehead Jonathan P.,O'Moore–Sullivan Trisha M.,Lee Paul,Franklin Michael,Klein Kerenaftali,Taylor Paul J.,Ferguson Maree,Coombes Jeff S.,Thomas Gethin P.,Cowin Gary J.,Kirkpatrick Carl M.J.,Prins Johannes B.,Hickman Ingrid J.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference80 articles.

1. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States;Charlton;Gastroenterology,2011

2. Systematic review: the epidemiology and natural history of non alcoholic fatty liver disease and non alcoholic steatohepatitis in adults;Vernon;Aliment Pharmacol Ther,2011

3. The diagnosis and management of non alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association;Chalasani;Hepatology,2012

4. Increased risk of cardiovascular disease and chronic kidney disease in NAFLD;Bonora;Nat Rev Gastroenterol Hepatol,2012

5. The challenge of developing novel pharmacological therapies for non alcoholic steatohepatitis;Schuppan;Liver Int,2010

Cited by 249 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocellular Interactions of Potential Nutraceuticals in the Management of Inflammatory NAFLD;Cell Biochemistry and Function;2024-09-05

2. S2k-Leitlinie Klinische Ernährung in der Hepatologie;Aktuelle Ernährungsmedizin;2024-08

3. Innovative treatments for obesity and NAFLD: A bibliometric study on antioxidants, herbs, phytochemicals, and natural compounds;Heliyon;2024-08

4. The Role of Antioxidants in the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review;Antioxidants;2024-06-29

5. Targeting cAMP signaling and phosphodiesterase 4 for liver disease treatment;Medicinal Chemistry Research;2024-06-26